US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,459.59

-10.6265-0.72%

Number of Gainers:8

Number of Losers:12

Number of Flat:- -

PE:- -

High:1,469.90

Open:1,469.76

Low:1,454.86

Close:1,470.19

Loading ...

Moderna Shares Rise 6.6% After CEO Stephane Bancel Buys Company's Shares

THOMSON REUTERS

Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run?

Moderna up 7% as CEO buys $5.0M, director buys $1.0M in common stock

Kenvue settles proxy fight with activist Starboard, appoints three directors

Moderna (MRNA) Stock Climbs as CEO and Director Make Strategic Insider Purchases

BUZZ-Moderna rises after CEO Stephane Bancel purchases shares

S&P 500 Futures Up In Premarket Trading; Option Care Health, Independence Realty Trust Lag

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1

Ocugen Q4 Profit From Operations USD -13.84 Million

THOMSON REUTERS

Ocugen Q4 Net Income USD -13.88 Million

THOMSON REUTERS

Ocugen Inc: Ocu400 Remains on Track to Meet 1H 2025 Recruitment Completion and Potential Bla/Maa Filings by Mid-2026

THOMSON REUTERS

Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results

Bank of America Securities Remains a Buy on Gilead Sciences (GILD)

3 Ultra-Cheap Dividend Stocks to Buy Right Now

Moderna Shares Rise 6.3% Premarket After CEO Stephane Bancel Buys Company's Shares

THOMSON REUTERS

Positive Outlook for Evonik: Buy Rating Supported by Strong FY-25 Guidance and Cost Savings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1459.5593,"timestamp":1741282791678,"preClose":1470.1858,"halted":0,"volume":41265723,"delay":0,"changeRate":-0.007228,"change":-10.626465,"pbRate":4.026038,"amount":2207233833.254406,"amplitude":0.01023,"prevYearClose":1274.8187,"fiveDayClose":1446.7607,"twentyDayClose":1373.9138,"turnoverRate":0.002668,"marketCap":1204195515183,"floatMarketCap":1182023846917,"peRate":31.895692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1469.9016,"amplitude":0.01023,"preClose":1470.1858,"low":1454.8619,"pbRate":"4.026038","latestPrice":1459.5941,"volume":41280572,"delay":0,"open":1469.7611,"prevYearClose":1274.8187,"prevWeekClose":1463.5875,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1446.7607,"twentyDayClose":1373.9138,"sixtyDayClose":1299.5834,"secType":"PLATE","market":"US","turnoverRate":0.002668,"peRate":31.895692,"marketCap":1204195515183,"floatMarketCap":1182023846917,"timestamp":1741282792835,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517106879","title":"Moderna Shares Rise 6.6% After CEO Stephane Bancel Buys Company's Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2517106879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517106879?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:32","pubTimestamp":1741185134,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nFWN3PO0UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4551","BK4534","BK4139","BK4532","BK4585","MRNA","BK4501","BK4588","BK4533","BK4568"],"gpt_icon":0},{"id":"2517949629","title":"Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517949629","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517949629?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:15","pubTimestamp":1741184103,"startTime":"0","endTime":"0","summary":"Have you been paying attention to shares of Gilead Sciences ?Shares have been on the move with the stock up 17.1% over the past month. The stock hit a new 52-week high of $117.39 in the previous session. Gilead Sciences has gained 24.2% since the start of the year compared to the 6% move for the Zacks Medical sector and the 6% return for the Zacks Medical - Biomedical and Genetics industry.The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on February 11, 2025, Gilead reported EPS of $1.9 versus consensus estimate of $1.67.For the current fiscal year, Gilead is expected to post earnings of $7.86 per share on $28.55 billion in revenues. This represents a 70.13% change in EPS on a -0.7% change in revenues. For the next fiscal year, the company is expected to earn $8.17 per share on $29.7 billion in revenues. This represents a year-over-year change of 3.9% and 4.01%,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-inc-gild-hits-141503605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BKVL7J92.USD","LU0289739699.SGD","LU1066053197.SGD","LU1430594728.SGD","LU1571399168.USD","IE00B3T34201.USD","BK4139","LU2087621335.USD","IE00BN0W2W23.USD","IE00B19Z3B42.SGD","BK4533","LU1066051498.USD","LU1839511570.USD","BK4007","IE00BZ1G4Q59.USD","LU0823416689.USD","IE0002270589.USD","BK4585","LU0234570918.USD","IE00BN0W2T93.GBP","LU0058720904.USD","BK4588","BK4568","BK4578","IE00BN0W2V16.EUR","LU1585245621.USD","JAZZ","LU2468319806.SGD","LU0889565916.HKD","LU0320765992.SGD","BK4550","IE00B19Z3581.USD","BK4532","BK4566","BK4583","LU2089984988.USD","IE00B7SZLL34.SGD","GILD","IE00BSNM7G36.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2517912798","title":"Moderna up 7% as CEO buys $5.0M, director buys $1.0M in common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912798","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517912798?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:57","pubTimestamp":1741183074,"startTime":"0","endTime":"0","summary":"Shares of Moderna (MRNA) are up 7% in pre-market trading at $32.56. Last night, the company disclosed that its CEO Stephane Bancel bought 160.3K sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-up-7-as-ceo-buys-5-0m-director-buys-1-0m-in-common-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-up-7-as-ceo-buys-5-0m-director-buys-1-0m-in-common-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4533","BK4501","BK4534","BK4139","BK4585","BK4532","BK4551","BK4548","MRNA","BK4588"],"gpt_icon":0},{"id":"2517914157","title":"Kenvue settles proxy fight with activist Starboard, appoints three directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2517914157","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517914157?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:35","pubTimestamp":1741181731,"startTime":"0","endTime":"0","summary":"UPDATE 3-Kenvue settles proxy fight with activist Starboard, appoints three directorsAdds shares in paragraph 4, background in paragraph 6. March 5  - Consumer health company Kenvue KVUE.N said on Wednesday it had appointed three new directors to its board as part of an agreement with activist investor Starboard Value.The appointments settle over four months of back and forth with the hedge fund since it built a stake in the Band-Aid maker in October, sparking criticism over the lackluster performance in the skin health and beauty segment, which houses brands such as Neutrogena and Aveeno.Kenvue said Starboard CEO Jeffrey Smith has joined the board along with two independent directors - Sarah Hofstetter, president of e-commerce company Profitero, and Erica Mann, former head of Bayer's BAYGn.DE consumer health unit.Kenvue's shares fell nearly 2% to $23 in late-morning trade.nominated CEO Smith and three candidates to Kenvue's board last month.Hofstetter and Mann were not part of Starboa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO17T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","BK4007","LU1894683264.USD","BK4585","LU1935042991.SGD","BK4559","LU0345770308.USD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU0466842654.USD","KVUE","LU1914381329.SGD","IE00B7SZLL34.SGD","LU0203345920.USD","LU2505996681.GBP","IE00BVYPNW00.USD","IE0002141913.USD","LU0122379950.USD","LU0098860793.USD","LU0289739699.SGD","IE0034235303.USD","LU1894683348.USD","JNJ","IE00B3T34201.USD","IE00B4R5TH58.HKD","LU1244550494.USD","LU2592432038.USD","BK4592","LU2602419157.SGD","IE00BDGV0183.EUR","LU0792757196.USD","BK4183","LU1244550221.USD","LU1059921491.USD","LU1674673428.USD","LU1732800096.USD","LU2129689605.HKD","LU2430703095.HKD","LU1585245621.USD","LU0345769128.USD","LU1221951129.SGD","LU0234572021.USD","LU0640476718.USD","SG9999002232.USD","LU1023059063.AUD","LU1066051225.USD","LU0320765646.SGD","BK4568","LU1244550577.SGD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2517272914","title":"Moderna (MRNA) Stock Climbs as CEO and Director Make Strategic Insider Purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2517272914","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517272914?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:28","pubTimestamp":1741181339,"startTime":"0","endTime":"0","summary":"Shares of the American pharmaceutical company Moderna ($MRNA) climbed over 8% in pre-market trading following strategic insider stock purchases by ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-mrna-stock-climbs-as-ceo-and-director-make-strategic-insider-purchases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-mrna-stock-climbs-as-ceo-and-director-make-strategic-insider-purchases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4139","BK4501","BK4588","BK4532","BK4548","BK4585","MRNA","BK4534","BK4551","BK4568"],"gpt_icon":0},{"id":"2517916124","title":"BUZZ-Moderna rises after CEO Stephane Bancel purchases shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916124","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916124?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:42","pubTimestamp":1741178520,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna rises after CEO Stephane Bancel purchases shares** Shares of vaccine maker Moderna MRNA.O rise 9.2% to $33.19 premarket** CEO Stephane Bancel has bought ~160,000 MRNA shares at roughly $3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO13X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4534","BK4501","BK4568","BK4585","BK4551","BK4139","BK4588","BK4533","BK4548","MRNA"],"gpt_icon":1},{"id":"2517167729","title":"S&P 500 Futures Up In Premarket Trading; Option Care Health, Independence Realty Trust Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167729","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517167729?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:30","pubTimestamp":1741177800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Huntington Ingalls Industries Inc.  was up 11.5% in pre-market trading, and Moderna Inc.  was up 9.1%.McCormick & Co. Inc. Com. Vtg. , Deutsche Bank AG , and Stellantis N.V.  were all posting gains of at least 6%. In early trading, Option Care Health Inc.  and Independence Realty Trust Inc.  had posted declines, falling 20.2% and 17.9%, respectively.Meanwhile S&P 500 futures were up 0.27%, with futures for the Dow Jones Industrial Average rising 0.20%. The Cboe Volatility Index futures were up 1.72%.In commodities news, Brent crude oil futures were down 1.18%, and gold futures were up 0.25%. Bitcoin was up 3.97% to $90,259.In afternoon trading, stocks in Europe are up, with the STOXX Europe 600 Index increasing 1.30% and the FTSE 100 Index climbing 0.41% from the previous close.U.S. stock markets open for trading at 9:30 a.m. ET.Data source:","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4118","HII","BK4187","LU0006061336.USD","BK4551","LU2065731478.USD","LU1064927863.SGD","LU0162691827.USD","BK4196","STLA","BK4588","BK4548","BK4585","VOO",".SPX","BK4099","LU0072461881.USD","BK4139","IRT","BK4534","LU1699723380.USD","BK4215","BK4566","OPCH","BK4212","BK4501","BK4532","SPY","DB","BK4552","MKC.V","BK4568"],"gpt_icon":1},{"id":"2517691597","title":"Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2517691597","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517691597?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:05","pubTimestamp":1741176300,"startTime":"0","endTime":"0","summary":"New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA (pemivibart) against LP.8.1 Centers for Disease Control reports LP.8.1, XEC and KP.3.1.1 together constitu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/05/3037297/0/en/Invivyd-Announces-Continued-Neutralizing-Activity-of-PEMGARDA-pemivibart-Against-Currently-Dominant-SARS-CoV-2-Variant-LP-8-1.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","BK4082","BK4551","BK4139","BK4588","BK4548","CDC","BK4585","ICU","BK4568","BK4535"],"gpt_icon":0},{"id":"2517991397","title":"Ocugen Q4 Profit From Operations USD -13.84 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991397?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLX1287E6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","OCGN","BK4139","BK4563"],"gpt_icon":0},{"id":"2517913974","title":"Ocugen Q4 Net Income USD -13.88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913974","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913974?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLX1287E6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4563","OCGN","BK4139"],"gpt_icon":0},{"id":"2517091324","title":"Ocugen Inc: Ocu400 Remains on Track to Meet 1H 2025 Recruitment Completion and Potential Bla/Maa Filings by Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2517091324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517091324?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLX1287E6:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4139","BK4568","OCGN"],"gpt_icon":0},{"id":"2517913794","title":"Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913794","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913794?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176120,"startTime":"0","endTime":"0","summary":"Reached an alignment with FDA on Phase 2/3 pivotal confirmatory clinical trial for OCU410ST for Stargardt disease potentially expediting clinical development by two to three years. Positive 2-year long-term data across multiple mutations of retinitis pigmentosa  from the Phase 1/2 clinical trial of OCU400 demonstrated a durable and statistically significant  improvement in visual function  in all evaluable treated subjects at two years when compared to untreated eyes. The OCU410ST Phase 2/3 clinical trial will randomize 51 subjects, 34 of whom will receive a single, subretinal, 200-μL injection of OCU410ST at a concentration of 1.5 x 1011 vector genomes /mL in the eye with worse visual acuity, and 17 of whom will serve as untreated controls. One-year data will be utilized for the BLA filing planned for 2027. 6-month data from Phase 1 of the OCU410ST GARDian clinical trial demonstrated considerably slower lesion growth (52%) from baseline in treated eyes versus untreated fellow eyes and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ocugen-provides-business-fourth-quarter-120200309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4532","BK4597","LU1917777945.USD","LU2237438978.USD","BK4563","LU0942090050.USD","BK4585","BK4516","LU2023250504.SGD","CAT","BK4520","LU1064131342.USD","LU0868494617.USD","IE00BD6J9T35.USD","BK4149","BK4201","IE00BSNM7G36.USD","LU0868494708.USD","LU1988902786.USD","OCGN","LU2264538146.SGD","LU1974910355.USD","LU2106854487.HKD","BK4568","ATMP","BK4588","EC"],"gpt_icon":0},{"id":"2517991313","title":"Bank of America Securities Remains a Buy on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991313?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:57","pubTimestamp":1741175855,"startTime":"0","endTime":"0","summary":"In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Gilead Sciences (GILD – Research Report), with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-gilead-sciences-gild?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-gilead-sciences-gild?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU0170899867.USD","LU0130102774.USD","GILD","LU0130103400.USD","LU0971096721.USD","LU1496350171.SGD","LU0417517546.SGD","IE00BBT3K403.USD","LU0208291251.USD","BK4550","LU0256863902.USD","LU1280957306.USD","LU1668664300.SGD","LU0098860793.USD","LU0648000940.SGD","LU1880398554.USD","LU1571399168.USD","BK4578","BAC","LU1883839398.USD","LU2133065610.SGD","LU0053666078.USD","BK4207","LU0109394709.USD","LU0320765992.SGD","LU1066051498.USD","BK4532","BK4139","BK4585","LU2087621335.USD","LU0058720904.USD","BK4588","LU2129689605.HKD","LU1363072403.SGD","IE00BLSP4452.SGD","LU0256863811.USD","BK4568","LU1201861165.SGD","LU0289739699.SGD","BK4583","LU1894683264.USD","LU1880398471.USD","LU1162221912.USD","BK4504","LU1791807156.HKD","IE00BLSP4239.USD","IE00BKVL7J92.USD","LU2129689431.USD","LU1201861249.SGD"],"gpt_icon":0},{"id":"2517913218","title":"3 Ultra-Cheap Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913218","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913218?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:00","pubTimestamp":1741172400,"startTime":"0","endTime":"0","summary":"Verizon, Toronto-Dominion Bank, and Pfizer all pay dividends yielding at least 4.9% at their current share prices.They have all been struggling in recent years, but in the long run, they could recover and produce strong gains for shareholders.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/05/3-ultra-cheap-dividend-stocks-to-buy-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["PFE","SG9999002224.SGD","LU1883839398.USD","LU0306807586.USD","LU0234572021.USD","LU0321505439.SGD","BK4533","BK4581","LU1066053197.SGD","IE00BBT3K403.USD","BK4588","BK4585","LU0225284248.USD","LU0456855351.SGD","IE0002270589.USD","LU0225771236.USD","BK4599","LU1066051498.USD","LU0122379950.USD","LU0321505868.SGD","SG9999011175.SGD","LU0170899867.USD","SG9999013999.USD","LU0306806265.USD","LU1894683348.USD","BK4568","IE000M9KFDE8.USD","LU1894683264.USD","LU0985481810.HKD","BK4550","LU0058720904.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1023059063.AUD","SG9999001176.SGD","SG9999002232.USD","IE00BLSP4452.SGD","LU1057294990.SGD","LU0289739699.SGD","SG9999003800.SGD","BK4534","BK4592","IE00B19Z3B42.SGD","SGXZ57979304.SGD","SG9999001176.USD","BK4007","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2517997665","title":"Moderna Shares Rise 6.3% Premarket After CEO Stephane Bancel Buys Company's Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2517997665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517997665?lang=en_us&edition=fundamental","pubTime":"2025-03-05 18:57","pubTimestamp":1741172224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4501","BK4533","BK4551","BK4585","BK4588","BK4568","BK4139","MRNA","BK4534","BK4532","BK4548"],"gpt_icon":0},{"id":"2517991743","title":"Positive Outlook for Evonik: Buy Rating Supported by Strong FY-25 Guidance and Cost Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991743","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991743?lang=en_us&edition=fundamental","pubTime":"2025-03-05 17:46","pubTimestamp":1741168006,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Andreas Heine has maintained their bullish stance on 0QDS stock, giving a Buy rating today. Andreas Heine has given his Buy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-evonik-buy-rating-supported-by-strong-fy-25-guidance-and-cost-savings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-evonik-buy-rating-supported-by-strong-fy-25-guidance-and-cost-savings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4535","BNTX","BK4585","BK4588","BK4568","BK4139","BK4548"],"gpt_icon":0}],"pageSize":16,"totalPage":19,"pageCount":3,"totalSize":304}]}}